GB2006193B - Nclusion complexes of prostacyclin and its derivatives their preparation and pharmaceutical compositions containing them - Google Patents

Nclusion complexes of prostacyclin and its derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
GB2006193B
GB2006193B GB7837834A GB7837834A GB2006193B GB 2006193 B GB2006193 B GB 2006193B GB 7837834 A GB7837834 A GB 7837834A GB 7837834 A GB7837834 A GB 7837834A GB 2006193 B GB2006193 B GB 2006193B
Authority
GB
United Kingdom
Prior art keywords
nclusion
prostacyclin
complexes
derivatives
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7837834A
Other languages
English (en)
Other versions
GB2006193A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Publication of GB2006193A publication Critical patent/GB2006193A/en
Application granted granted Critical
Publication of GB2006193B publication Critical patent/GB2006193B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB7837834A 1977-09-23 1978-09-22 Nclusion complexes of prostacyclin and its derivatives their preparation and pharmaceutical compositions containing them Expired GB2006193B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77CI1770A HU179141B (ja) 1977-09-23 1977-09-23

Publications (2)

Publication Number Publication Date
GB2006193A GB2006193A (en) 1979-05-02
GB2006193B true GB2006193B (en) 1982-05-26

Family

ID=10994670

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7837834A Expired GB2006193B (en) 1977-09-23 1978-09-22 Nclusion complexes of prostacyclin and its derivatives their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
JP (1) JPS5456685A (ja)
AT (1) AT369362B (ja)
BE (1) BE870646A (ja)
CH (1) CH637388A5 (ja)
CS (1) CS200242B2 (ja)
DD (1) DD138600A5 (ja)
DE (1) DE2840142A1 (ja)
DK (1) DK420778A (ja)
FI (1) FI65912C (ja)
FR (1) FR2404006A1 (ja)
GB (1) GB2006193B (ja)
GR (1) GR65001B (ja)
HU (1) HU179141B (ja)
IL (1) IL55569A (ja)
IT (1) IT1160661B (ja)
NL (1) NL7809643A (ja)
PL (1) PL121664B1 (ja)
SE (1) SE447574B (ja)
SU (1) SU847914A3 (ja)
YU (1) YU220678A (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds
US4352793A (en) * 1979-04-26 1982-10-05 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising bencyclane fumarate and cyclodextrin
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3740838A1 (de) * 1987-11-27 1989-06-08 Schering Ag Cyclodextrinclathrate von 5-cyano-prostacyclinderivaten und ihre verwendung als arzneimittel
WO2005073223A1 (ja) 2004-01-29 2005-08-11 Eisai R & D Management Co., Ltd. マクロライド系化合物の安定化方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (ja) * 1970-06-10 1975-02-04
US3953435A (en) * 1974-01-10 1976-04-27 Ono Pharmaceutical Company Aldehyde derivatives of prostaglandins
JPS5395958A (en) * 1977-01-31 1978-08-22 Ono Pharmaceut Co Ltd Prostaglandin analogues and process for their preparation
US4178367A (en) * 1977-02-21 1979-12-11 Ono Pharmaceutical Co. Ltd. Prostaglandin I2 analogues
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds

Also Published As

Publication number Publication date
GB2006193A (en) 1979-05-02
YU220678A (en) 1983-10-31
PL121664B1 (en) 1982-05-31
CH637388A5 (de) 1983-07-29
FI65912C (fi) 1984-08-10
BE870646A (fr) 1979-01-15
JPS5456685A (en) 1979-05-07
HU179141B (ja) 1982-08-28
IT7869160A0 (it) 1978-09-19
DD138600A5 (de) 1979-11-14
FI782878A (fi) 1979-03-24
SE447574B (sv) 1986-11-24
ATA677478A (de) 1982-05-15
AT369362B (de) 1982-12-27
SE7809946L (sv) 1979-03-24
DK420778A (da) 1979-03-24
NL7809643A (nl) 1979-03-27
SU847914A3 (ru) 1981-07-15
FR2404006A1 (fr) 1979-04-20
GR65001B (en) 1980-06-12
FI65912B (fi) 1984-04-30
IT1160661B (it) 1987-03-11
FR2404006B1 (ja) 1981-07-31
PL209773A1 (pl) 1979-06-04
IL55569A (en) 1981-12-31
CS200242B2 (en) 1980-08-29
DE2840142A1 (de) 1979-04-05
IL55569A0 (en) 1978-12-17

Similar Documents

Publication Publication Date Title
NZ188320A (en) Thienothiazine derivatives preparation and pharmaceutical compositions
IL51074A0 (en) Isoquinolinium derivatives their preparation and pharmaceutical compositions containing them
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
NZ187849A (en) Prostaglandin i derivatives and pharmaceutical compositions
NZ188976A (en) Prostacyclin derivatives and pharmaceutical compositions
IL50869A0 (en) Novel imidazole derivatives their preparation and pharmaceutical compositions containing them
JPS51146449A (en) Preparation of novel cromanci compound and pharmaceutical composition
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
IL51812A0 (en) New isothiazolopyridine derivatives their preparation and pharmaceutical compositions containing them
IL50230A0 (en) Novel imidazole derivatives their preparation and pharmaceutical compositions containing them
DE2861646D1 (en) Derivatives of furyl compounds, their preparation and pharmaceutical compositions containing them
GB2006193B (en) Nclusion complexes of prostacyclin and its derivatives their preparation and pharmaceutical compositions containing them
GB2001980B (en) Dioxazocine derivatives their preparation and compositions containing them
IL53642A0 (en) New indoloquinolizine derivatives their preparation and pharmaceutical compositions containing them
GB2011393B (en) Preparation of 1-hydroxyaphorphine derivatives
IL52006A0 (en) Novel nephthalene derivatives their preparation and pharmaceutical compositions containing them
IL53009A0 (en) New imidazoisoquinoline derivatives their preparation and pharmaceutical compositions containing them
NZ181146A (en) Benzocycloheptathiophene derivatives and pharmaceutical compositions
NZ185318A (en) Derivatives of 1-phenoxy-3-amino-2-propanol and pharmaceutical compositions
IL52962A0 (en) New perhydroindolinol derivatives their preparation and pharmaceutical compositions containing them
NZ185566A (en) Tetrametric complexes of malonylurea derivatives and pharmaceutical compositions
NZ186758A (en) Derivatives of 1-amino-3-aryloxy-2-propanol and pharmaceutical compositions containing them
IL51630A0 (en) New derivatives of sandwicin their preparation and pharmaceutical compositions containing them
NZ183136A (en) Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions
IL54509A0 (en) Novel derivatives of 6,7-benzomorphane, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee